Etravirine (Intelence) is a medication that's used as part of an antiretroviral (ARV) therapy to treat human immunodeficiency virus (HIV) infections. It's typically given to people who might've developed resistance to other HIV medications. Etravirine (Intelence) comes as tablets that are swallowed whole or dissolved in liquid for people who have trouble swallowing. Some side effects of this medication are changes in cholesterol levels and rash. Etravirine (Intelence) is available as both a brand-name and generic medication.
Treatment of HIV infection in people 2 years of age and older
Etravirine (Intelence) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It blocks an enzyme found in HIV called reverse transcriptase that usually helps the virus make copies of itself. By blocking reverse transcriptase, etravirine (Intelence) prevents the HIV virus from doing so and from spreading.
Source: DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Rash
Less common
Blurred vision
burning, numbness, tingling, or painful sensations
dizziness
headache
nervousness
pounding in the ears
slow or fast heartbeat
unsteadiness or awkwardness
weakness in the arms, hands, legs, or feet
Rare
Blistering, peeling, or loosening of the skin
chills
hoarseness
irritation
joint pain, stiffness, or swelling
red skin lesions, often with a purple center
red, irritated eyes
redness of the skin
sores, ulcers, or white spots in the mouth or on the lips
swelling of the eyelids, face, lips, hands, or feet
tightness in the chest
trouble with breathing or swallowing
unusual tiredness or weakness
Incidence not known
Dark urine
general feeling of tiredness or weakness
headache
light-colored stools
stomach pain, continuing
swollen, painful, or tender lymph glands in the neck, armpit, or groin
vomiting
yellow eyes or skin
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
Stomach pain
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Available for people 2 years of age and older who weigh at least 22 lbs
Can dissolve tablet with liquid to make it easier for people who have trouble swallowing pills to take
No need for dose changes if you're pregnant
Might work well for people who didn’t see benefits with other HIV medications in the same class
Need to take twice daily after meals
Interacts with many medications, including some other HIV medications (e.g., Tivicay (dolutegravir), atazanavir (Reyataz))
Not an option for people who are just starting HIV treatment
Doesn't come in a combination pill
Take etravirine (Intelence) after a meal to help your body absorb the medication better.
If you have trouble swallowing, dissolve etravirine (Intelence) tablets with 1 teaspoon of water in a cup, and stir well until the mixture looks milky. Then, add 3 teaspoons of liquid (e.g., water, orange juice, milk) to the cup, and drink the mixture right away. Finally, add small amounts of liquid to any leftovers, stir, and drink again to make sure you've taken all the medication.
Don't mix etravirine (Intelence) tablets in warm or carbonated drinks. It's not clear how these types of liquids affect how well the medication works.
Make sure to get your routine blood tests done on time while you’re taking etravirine (Intelence). This helps your provider make sure the medication is working for you and not causing side effects.
Etravirine (Intelence) can cause a life-threatening allergic reaction. If you experience rash with fever, body aches, extreme tiredness, mouth sores, blisters, or facial swelling, get medical attention right away.
Let your provider or pharmacist know what medications you're taking or planning to take, including over-the-counter products and supplements. Etravirine (Intelence) can interact with many medications. These interactions can affect how well your medications work or how safe they are for you.
If your child is taking etravirine (Intelence), tell their provider if your child experiences any changes in weight. Your child's dose is based on their weight, so the dose might need to be changed depending on how much the change in weight is.
Talk to your provider before stopping etravirine (Intelence) or any of your HIV medications. Doing so can cause the virus to spread and become harder to treat.
Etravirine (Intelence) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factor: Females | Children
Etravirine (Intelence) can cause severe skin reactions and allergic reactions that are sometimes life-threatening. In studies, some people developed a rash within the first couple of months of treatment. Watch out for allergic reactions. If you experience a severe rash with fever, general discomfort, muscle or joint pain, mouth sores, blisters, or facial swelling, stop taking etravirine (Intelence) right away and get medical attention.
If you have a serious allergic reaction, your provider will probably switch you to a different medication to treat HIV. Your provider might also check your liver function through blood work since severe allergic reactions can sometimes lead to liver injury.
Taking combination ARV therapy, such as etravirine (Intelence) with other HIV medications, can cause changes to your immune system called immune reconstitution syndrome. This medical condition happens when your immune system becomes more active after you start combination therapy. Your immune system begins to fight off different infections that it was too weak to fight off before you started treatment. In rare cases, your immune response might improve so much with treatment that it starts to attack normal cells in your body (autoimmune). You can develop immune reconstitution syndrome as early as during the first few weeks of treatment or many months later. Tell your healthcare provider right away if you start having any new symptoms, such as fever, pain, hair loss, bulging eyes, or sweating, after starting etravirine (Intelence).
Risk factors: Taking HIV medications
Rarely, people taking HIV medications, such as etravirine (Intelence), have experienced changes in body fat. These changes include fat buildup in the back of the neck, breast, and around the middle of your body. Some people also lost fat from the legs, arms, and face. It's not clear whether etravirine (Intelence) causes these changes to body fat, why this happens, and whether it will affect your health in the future. Let your provider know if these changes occur while you're taking etravirine (Intelence).
Some medications can interfere with how well your body gets rid of etravirine (Intelence) from your system. This can affect the amount of etravirine (Intelence) in your body, how well it works, and the risk of side effects.
Taking medications like clarithromycin or fluconazole (Diflucan) can raise the amount of etravirine (Intelence) in your body and raise your risk for serious side effects from the HIV medication. On the other hand, taking certain seizure medications (e.g., carbamazepine (Tegretol)) or the tuberculosis medication rifampin (Rifadin) can lower the amount of etravirine (Intelence) in your body. This can make etravirine (Intelence) not work as well to treat your HIV.
Etravirine (Intelence) also interferes with how your body gets rid of other medications. For example, the amount of diazepam (Valium) that your body absorbs can go up when taken with etravirine (Intelence). This can raise your risk of side effects from the sedative, such as sleepiness.
Because of the potential for interactions with etravirine (Intelence) and various medications, tell your provider and pharmacist about all the medications you take or plan to take. They can make sure your medications are safe to take together.
Adults: The typical dose is 200 mg by mouth twice daily after a meal.
Children age 2 years and older who weigh at least 22 lbs: The dose will depend on your child’s weight. The typical dose ranges from 100 mg to 200 mg by mouth twice daily after a meal.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Treatment of HIV infection in people 2 years of age and older
Treatment of HIV infection in people ages 3 months and older
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Centers for Disease Control and Prevention. (2022). HIV treatment as prevention.
Centers for Disease Control and Prevention. (2023). Human immunodeficiency virus (HIV).
Drugs and Lactation Database (LactMed). (2023). Etravirine.
Eraikhuemen, N., et al. (2008). Combating non-nucleoside reverse transcriptase inhibitor resistance with a focus on etravirine (intelence) for HIV-1 infection. P&T: A Peer-Reviewed Journal for Formulary Management.
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. (2021). Non-nucleoside reverse transcriptase inhibitor-based regimens. HIV.gov.
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. (2022). What to start: Initial combination antiretroviral regimens for people with HIV. HIV.gov.
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. (2023). What's new in the guidelines. HIV.gov.
HIV/AIDS Glossary. (n.d.). Immune reconstitution inflammatory syndrome (IRIS). HIV.gov.
HIV/AIDS Glossary. (n.d.). Non-nucleoside reverse transcriptase inhibitor (NNRTI). HIV.gov.
HIV/AIDS Glossary. (n.d.). Reverse transcriptase (RT).
HIV.gov. (2021). HIV treatment: Drug resistance.
MedlinePlus. (2020). Creatine kinase.
Thapa, S., et al. (2023). Immune reconstitution inflammatory syndrome. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.